Mirugen is a preclinical biotechnology company identifying the optimal set of cellular instructions ('transcription factors') to ask one cell type to become another. Our lead program is focused on unlocking innate repair mechanisms to restore sight, initially for the 1.5 million individuals worldwide suffering from Retinitis Pigmentosa.
Company Details
- Employees
- 1
- Founded
- 2022
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.mirugen.com
Mirugen Questions
Mirugen's website is http://www.mirugen.com
Mirugen's LinkedIn profile is https://www.linkedin.com/company/mirugen
Mirugen has
1 employees.
View email and phone details for 1
employees at Mirugen.
Mirugen's industry is
Biotechnology Research
Mirugen's top competitors are
Oncores Medical,
Kinoxis Therapeutics Pty Ltd,
Andhealth,
Seetreat Medical,
Brandon Capital,
Baymatob,
Misti,
Amplificare,
Meizon Innovation,
Currus Biologics Pty Ltd.
Mirugen's categories are Biotechnology Research
Mirugen's founding year is 2022
